Developer of prophylactic therapeutics designed for bleeding and thrombosis disorders. The company's therapeutics accumulate, modulate, balance, and at times recruit endogenous clotting factors alread...

Drug Discovery
Healthcare
Frederiksberg, Denmark
Founded 2019
26 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$353M
Last Round
Later Stage VC (Series C)
Oct 2025

Get the full picture

Create a free account to unlock Hemab's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required